//
home

Latest Post

Facing Down Lung Cancer

This month another promising new medication gains approval and joins the fight against cancer: Opdivo (nivolumab), manufactured by Bristol-Myers Squibb. Opdivo was approved by the U.S. Food and Drug Administration (FDA) on March 5, 2015 to treat metastatic squamous non-small cell lung cancer; previously this medication was approved for melanoma treatment. Non-small cell lung cancer … Continue reading

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 157 other followers

Twitter Updates

Follow

Get every new post delivered to your Inbox.

Join 157 other followers